Update shared on 06 Sep 2025
Fair value Increased 29%Upward revisions to both revenue growth forecasts and net profit margin expectations for Zumiez have prompted analysts to raise their fair value target from $14.00 to $18.00.
What's in the News
- Issued Q3 earnings guidance with net sales projected at $232–$237 million, expected comparable sales growth of 5.5%–7.5%, operating margins of 2.3%–3.3%, and EPS of $0.19–$0.29.
- Completed buyback of 597,000 shares (3.36% of outstanding) for $7.82 million.
- Added to Russell 2000 Value-Defensive Index.
- Added to Russell 2000 Defensive Index.
- Auditor changed from Moss Adams LLP to Baker Tilly US, LLP due to firm merger.
Valuation Changes
Summary of Valuation Changes for Zumiez
- The Consensus Analyst Price Target has significantly risen from $14.00 to $18.00.
- The Consensus Revenue Growth forecasts for Zumiez has significantly risen from 1.7% per annum to 2.8% per annum.
- The Net Profit Margin for Zumiez has significantly risen from 2.46% to 3.05%.
Have other thoughts on Zumiez?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.